S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

Oragenics News Headlines (NASDAQ:OGEN)

$0.43
-0.01 (-2.27 %)
(As of 10/21/2019 04:00 PM ET)
Today's Range
$0.43
Now: $0.43
$0.46
50-Day Range
$0.39
MA: $0.49
$0.65
52-Week Range
$0.35
Now: $0.43
$1.67
Volume146,300 shs
Average Volume1.15 million shs
Market Capitalization$19.83 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Oragenics (NASDAQ OGEN) News Headlines

Source:
DateHeadline
OGEN.K - Oragenics Inc Profile | ReutersOGEN.K - Oragenics Inc Profile | Reuters
www.reuters.com - October 21 at 6:00 AM
Oragenics Inc.Oragenics Inc.
www.barrons.com - October 10 at 6:12 PM
Zacks: Analysts Expect Oragenics, Inc. (NASDAQ:OGEN) to Post -$0.09 Earnings Per ShareZacks: Analysts Expect Oragenics, Inc. (NASDAQ:OGEN) to Post -$0.09 Earnings Per Share
www.americanbankingnews.com - October 7 at 10:10 PM
OGEN: Phase 2 Trial of AG013 More Than 2/3rd Enrolled…OGEN: Phase 2 Trial of AG013 More Than 2/3rd Enrolled…
finance.yahoo.com - October 3 at 4:29 PM
Oragenics Presents Interim Data on The AG013 Phase 2 Clinical Trial at the European Society for Medical Oncology Congress 2019Oragenics Presents Interim Data on The AG013 Phase 2 Clinical Trial at the European Society for Medical Oncology Congress 2019
finance.yahoo.com - September 30 at 8:27 AM
Oragenics, Inc. Announces Phase 2 Clinical Trial of AG013 Reaches Enrollment of 158 PatientsOragenics, Inc. Announces Phase 2 Clinical Trial of AG013 Reaches Enrollment of 158 Patients
finance.yahoo.com - September 25 at 5:04 PM
Oragenics, Inc. to Present Interim Data on AG013 at the European Society of Medical Oncology CongressOragenics, Inc. to Present Interim Data on AG013 at the European Society of Medical Oncology Congress
finance.yahoo.com - September 23 at 4:47 PM
Who Has Been Buying Oragenics, Inc. (NYSEMKT:OGEN) Shares?Who Has Been Buying Oragenics, Inc. (NYSEMKT:OGEN) Shares?
finance.yahoo.com - September 10 at 12:44 PM
Oragenics, Inc. to Present Overview of Lantibiotics Pipeline at the Annual Military Health System Research SymposiumOragenics, Inc. to Present Overview of Lantibiotics Pipeline at the Annual Military Health System Research Symposium
finance.yahoo.com - August 20 at 10:35 AM
Oragenics, Inc. (OGEN)Oragenics, Inc. (OGEN)
seekingalpha.com - August 15 at 10:59 AM
Oragenics, Inc. (NYSEMKT:OGEN): What Does Its Beta Value Mean For Your Portfolio?Oragenics, Inc. (NYSEMKT:OGEN): What Does Its Beta Value Mean For Your Portfolio?
finance.yahoo.com - July 10 at 3:21 PM
Recent Peer-Reviewed Publication on Oragenics, Inc.’s Lantibiotic Antimicrobial Compound Identifies Alternative Mechanism of ActionRecent Peer-Reviewed Publication on Oragenics, Inc.’s Lantibiotic Antimicrobial Compound Identifies Alternative Mechanism of Action
finance.yahoo.com - June 17 at 3:21 PM
OGEN: New Pre-Clinical Data Shows Lantibiotic OG253 Safe and Well Tolerated…OGEN: New Pre-Clinical Data Shows Lantibiotic OG253 Safe and Well Tolerated…
finance.yahoo.com - June 7 at 3:17 PM
Oragenics up 12% on advancement of oral mucositis candidateOragenics up 12% on advancement of oral mucositis candidate
seekingalpha.com - May 20 at 3:17 PM
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel